Skip to main content

NeuroMetrix, Inc.

NURODelisted May 1, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001289850

NeuroMetrix, Inc. was delisted on May 1, 2025; its insiders filed their last Form 4 on May 5, 2025; 14 institutions reported holding it in 13F filings for Q1 2025, worth $599.9K in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in NeuroMetrix, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
17
0 vs. Q2 2022
Shares held
572.9K
+10.4K (+1.9%) vs. Q2 2022
Total value
$1.59M
−$474.8K (−22.9%) vs. Q2 2022
New holders
2
4 more added
Sold out
2
4 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NURO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 17 institutions
Q1 2021: 11 institutionsQ2 2021: 14 institutionsQ3 2021: 21 institutionsQ4 2021: 17 institutionsQ1 2022: 17 institutionsQ2 2022: 17 institutionsQ3 2022: 17 institutionsQ4 2022: 15 institutionsQ1 2023: 12 institutionsQ2 2023: 13 institutionsQ3 2023: 14 institutionsQ4 2023: 13 institutionsQ1 2024: 12 institutionsQ2 2024: 11 institutionsQ3 2024: 16 institutionsQ4 2024: 16 institutionsQ1 2025: 14 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $1.59M
Q1 2021: $967.0KQ2 2021: $1.19MQ3 2021: $7.13MQ4 2021: $3.11MQ1 2022: $2.04MQ2 2022: $2.07MQ3 2022: $1.59MQ4 2022: $810.8KQ1 2023: $776.1KQ2 2023: $423.2KQ3 2023: $227.1KQ4 2023: $340.2KQ1 2024: $130.7KQ2 2024: $205.1KQ3 2024: $247.6KQ4 2024: $364.8KQ1 2025: $599.9KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NURO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 202514$599.9K
Q4 202416$364.8K
Q3 202416$247.6K
Q2 202411$205.1K
Q1 202412$130.7K
Q4 202313$340.2K
Q3 202314$227.1K
Q2 202313$423.2K
Q1 202312$776.1K
Q4 202215$810.8K
Q3 202217$1.59M
Q2 202217$2.07M
Q1 202217$2.04M
Q4 202117$3.11M
Q3 202121$7.13M
Q2 202114$1.19M
Q1 202111$967.0K

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding NeuroMetrix, Inc.; share changes are against Q2 2022.

Institutions holding NURO in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc350,029$977.0K0.00%+34,892+11.1%Added
Geode Capital Management, LLC55,463$154.0K0.00%+526+1.0%Added
BlackRock Inc.38,050$106.0K0.00%00.0%Unchanged
Citadel Advisors LLC34,699$97.0K0.00%+10,652+44.3%Added
Renaissance Technologies LLC28,200$79.0K0.00%−15,913−36.1%Reduced
State Street Corp18,170$51.0K0.00%00.0%Unchanged
Northern Trust Corp11,059$31.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.10,000$28.0K0.00%00.0%Unchanged
Millennium Management LLC10,146$28.0K0.00%+10,146New
Bank of America Corp9,370$26.0K0.00%−20,780−68.9%Reduced
UBS Group AG3,318$9.00K0.00%+2,901+695.7%Added
Tucker Asset Management LLC3,625$6.02K0.00%00.0%Unchanged
Stephens Consulting, LLC500$1.40K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)217$1.00K0.00%+217New
Morgan Stanley3$00.00%−147−98.0%Reduced
Wells Fargo & Company47$00.00%−1−2.1%Reduced
IFP Advisors, Inc12––00.0%Unchanged
Two Sigma Securities, LLC0$00.00%−11,876−100.0%Sold out
Geneos Wealth Management Inc.0$00.00%−200−100.0%Sold out